Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity
Fultang, Livingstone, Booth, Sarah, Yogev, Orli, Martins da Costa, Barbara, Tubb, Vanessa, Panetti, Silvia, Stavrou, Victoria, Scarpa, Ugo, Jankevics, Andris, Lloyd, Gavin, Southam, Andrew, Lee, Steven P., Dunn, Warwick B., Chesler, Louis, Mussai, Francis, De Santo, Carmela
Published in Blood (03.09.2020)
Published in Blood (03.09.2020)
Get full text
Journal Article
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
Nijhuis, Anke, Sikka, Arti, Yogev, Orli, Herendi, Lili, Balcells, Cristina, Ma, Yurui, Poon, Evon, Eckold, Clare, Valbuena, Gabriel N., Xu, Yuewei, Liu, Yusong, da Costa, Barbara Martins, Gruet, Michael, Wickremesinghe, Chiharu, Benito, Adrian, Kramer, Holger, Montoya, Alex, Carling, David, Want, Elizabeth J., Jamin, Yann, Chesler, Louis, Keun, Hector C.
Published in Nature communications (16.03.2022)
Published in Nature communications (16.03.2022)
Get full text
Journal Article
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Dubiella, Christian, Pinch, Benika J., Koikawa, Kazuhiro, Zaidman, Daniel, Poon, Evon, Manz, Theresa D., Nabet, Behnam, He, Shuning, Resnick, Efrat, Rogel, Adi, Langer, Ellen M., Daniel, Colin J., Seo, Hyuk-Soo, Chen, Ying, Adelmant, Guillaume, Sharifzadeh, Shabnam, Ficarro, Scott B., Jamin, Yann, Martins da Costa, Barbara, Zimmerman, Mark W., Lian, Xiaolan, Kibe, Shin, Kozono, Shingo, Doctor, Zainab M., Browne, Christopher M., Yang, Annan, Stoler-Barak, Liat, Shah, Richa B., Vangos, Nicholas E., Geffken, Ezekiel A., Oren, Roni, Koide, Eriko, Sidi, Samuel, Shulman, Ziv, Wang, Chu, Marto, Jarrod A., Dhe-Paganon, Sirano, Look, Thomas, Zhou, Xiao Zhen, Lu, Kun Ping, Sears, Rosalie C., Chesler, Louis, Gray, Nathanael S., London, Nir
Published in Nature chemical biology (01.09.2021)
Published in Nature chemical biology (01.09.2021)
Get full text
Journal Article
Palbociclib releases the latent differentiation capacity of neuroblastoma cells
Ferguson, Kirsty M., Gillen, Sarah L., Chaytor, Lewis, Poon, Evon, Marcos, Daniel, Gomez, Roshna Lawrence, Woods, Laura M., Mykhaylechko, Lidiya, Elfari, Louis, Martins da Costa, Barbara, Jamin, Yann, Carroll, Jason S., Chesler, Louis, Ali, Fahad R., Philpott, Anna
Published in Developmental cell (09.10.2023)
Published in Developmental cell (09.10.2023)
Get full text
Journal Article
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Tucker, Elizabeth R, Jiménez, Irene, Chen, Lindi, Bellini, Angela, Gorrini, Chiara, Calton, Elizabeth, Gao, Qiong, Che, Harvey, Poon, Evon, Jamin, Yann, Martins Da Costa, Barbara, Barker, Karen, Shrestha, Sumana, Hutchinson, J Ciaran, Dhariwal, Simran, Goodman, Angharad, Del Nery, Elaine, Gestraud, Pierre, Bhalshankar, Jaydutt, Iddir, Yasmine, Saberi-Ansari, Elnaz, Saint-Charles, Alexandra, Geoerger, Birgit, Marques Da Costa, Maria Eugénia, Pierre-Eugène, Cécile, Janoueix-Lerosey, Isabelle, Decaudin, Didier, Nemati, Fariba, Carcaboso, Angel M, Surdez, Didier, Delattre, Olivier, George, Sally L, Chesler, Louis, Tweddle, Deborah A, Schleiermacher, Gudrun
Published in Clinical cancer research (03.04.2023)
Published in Clinical cancer research (03.04.2023)
Get full text
Journal Article
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Berlak, Mareike, Tucker, Elizabeth, Dorel, Mathurin, Winkler, Annika, McGearey, Aleixandria, Rodriguez-Fos, Elias, da Costa, Barbara Martins, Barker, Karen, Fyle, Elicia, Calton, Elizabeth, Eising, Selma, Ober, Kim, Hughes, Deborah, Koutroumanidou, Eleni, Carter, Paul, Stankunaite, Reda, Proszek, Paula, Jain, Neha, Rosswog, Carolina, Dorado-Garcia, Heathcliff, Molenaar, Jan Jasper, Hubank, Mike, Barone, Giuseppe, Anderson, John, Lang, Peter, Deubzer, Hedwig Elisabeth, Künkele, Annette, Fischer, Matthias, Eggert, Angelika, Kloft, Charlotte, Henssen, Anton George, Boettcher, Michael, Hertwig, Falk, Blüthgen, Nils, Chesler, Louis, Schulte, Johannes Hubertus
Published in Molecular cancer (10.06.2022)
Published in Molecular cancer (10.06.2022)
Get full text
Journal Article
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
George, Sally L, Lorenzi, Federica, King, David, Hartlieb, Sabine, Campbell, James, Pemberton, Helen, Toprak, Umut H, Barker, Karen, Tall, Jennifer, da Costa, Barbara Martins, van den Boogaard, Marlinde L, Dolman, M Emmy M, Molenaar, Jan J, Bryant, Helen E, Westermann, Frank, Lord, Christopher J, Chesler, Louis
Published in EBioMedicine (01.09.2020)
Published in EBioMedicine (01.09.2020)
Get full text
Journal Article
COMBINATION THERAPIES TARGETING ALK-ABERRANT NEUROBLASTOMA IN PRECLINICAL MODELS
Tucker, Elizabeth, Jimenez, Irene, Chen, Lindi, Bellini, Angela, Gorrini, Chiara, Calton, Elizabeth, Gao, Qiong, Che, Harvey, Poon, Evon, Jamin, Yann, Martins Da Costa, Barbara, Barker, Karen, Shrestha, Sumana, Hutchinson, Ciaran, Dhariwal, Simran, Goodman, Angharad, Elaine Del Nery, Gestraud, Pierre, Bhalshankar, Jaydutt, Iddir, Yasmine, Saberi-Ansari, Elnaz, Saint-Charles, Alexandra, Geoerger, Birgit, Jenny Marques Da Costa, Pierre-Eugene, Cecile, Janouiex, Isabelle, Decaudin, Didier, Nemati, Fariba, Carcaboso, Angel, Surdez, Didier, Delattre, Olivier, George, Sally, Chesler, Louis, Tweddle, Deborah, Schleiermacher, Gudrun
Published in bioRxiv (02.11.2022)
Published in bioRxiv (02.11.2022)
Get full text
Paper
Indisulam targets RNA splicing and metabolism to serve as a novel therapeutic strategy for high-risk neuroblastoma
Nijhuis, Anke, Sikka, Arti, Yogev, Orli, Herendi, Lili, Eckold, Clare, Valbuena, Gabriel, Liu, Yusong, Kouloura, Eirini, Poon, Evon, Martins Da Costa, Barbara, Benito, Adrian, Kramer, Holger, Montoya, Alex, Carling, David, Want, Elizabeth J, Jamin, Yann, Chesler, Louis, Keun, Hector C
Published in bioRxiv (19.12.2020)
Published in bioRxiv (19.12.2020)
Get full text
Paper